StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics. Our discovery platform, Polaris™, applies multimodal AI to clinical data, identifying prognostic and predictive biomarkers that enable more equitable and individualized treatment strategies across solid-tumor cancers. Polaris™ Breast, the company’s first diagnostic, assesses metastatic risk in early breast cancer directly from digitized histology slides, supporting better treatment decisions. Retrospectively validated on thousands of patients from Phase III trials and real-world clinical settings, Polaris™ Breast is available for research use only and is undergoing regulatory approval in the EU and US.
| Website | https://stratifai.com |
| Employees | 14 (13 on RocketReach) |
| Founded | 2023 |
| Address | Karl-Liebknecht-Str. 29A, Berlin, Berlin 10178, DE |
| Industry | Hospitals and Health Care |
| Keywords | Next Generation Sequencing, Artificial Intelligence, Cancer Diagnostics, Precision Oncology, Biomarker Development, Personalized Medicine, Cancer Biomarkers, Machine Learning, Deep Learning, Genomics, Oncology, Drug Discovery, Ai Healthcare, Big Data Analytics, Data Science, Biotechnology, Medical Technology, Healthcare It, Predictive Analytics, Clinical Research |
| Competitors | DataRobot, H2O.ai, Altair RapidMiner, Alteryx, Dataiku, KNIME, SAS, IBM, Microsoft, Google +51 more (view full list) |
Looking for a particular StratifAI employee's phone or email?
Omar Nahhas is the CEO and Co-founder of StratifAI.
13 people are employed at StratifAI.
StratifAI is based in Berlin, Berlin.